Anti-IFNA1 Monoclonal antibody, PerCP/Cy5.5®

Transcription factors of the interferon regulatory factor (IRF) family are major regulators of the early immune responses against viral infections. In particular, IRF1, IRF2, IRF3 and IRF7 of mammals are known to regulate the expression of type I interferons (IFNs), which constitute the obligate cytokines for antiviral defense. We therefore cloned the coding sequence of Atlantic salmon (As) IRF1, IRF2, IRF3 and IRF7B. Expression profiles were studied in Atlantic salmon TO cells after poly I:C (dsRNA) transfection, treatment with recombinant salmon IFNa1 and infection with infectious salmon anemia virus (ISAV). The main findings were that AsIRF1 was earliest up-regulated by all stimuli, while AsIRF3 and AsIRF7 had a similar activation profile induced at a slightly later time point. The ability to induce the Atlantic salmon IFNa1 promoter was measured in a luciferase reporter assay The results showed that AsIRF1. AsIRF3 and AsIRF7B were able to induce the promoter in a dose-dependant manner. AsIRF2 repressed the promoter, while AsIRF7A and a splicing variant (AsIRF3D) lacking the interaction domain had almost no effect. Combination of AsIRF1 and AsIRF3 had a synergistic stimulatory effect on the promoter compared to each of the two IRFs alone. Overall, our findings suggest that AsIRF3 is the main regulator of salmon IFNa1 production along with AsIRF1, which is less potent. This confirms a similar role for salmon IRF3 as mammalian IRF3 to be one of the main IRFs eliciting salmon IFNa1 production Surprisingly. AsIRF7A and AsIRF7B seemed to have a lesser role in salmon IFNa1 induction, which may indicate that these factors have a larger role in activating other IFN genes or interferon stimulatory genes of Atlantic salmon (C) 2010 Elsevier Ltd All rights reserved.

We previously reported a natural antisense (AS) RNA as an important modulator of human interferon-Alpha1 (IFNA1) mRNA levels. Here, we identified the guinea pig (Cavia porcellus) IFNA1 gene to enable a proof-of-concept experiment to be performed to confirm that the AS-mRNA regulatory axis exerts in vivo control over innate immunity. We selected a guinea pig model system for influenza virus infection because guinea pigs encode a functional M x 1 gene, an important anti-viral effector in the type I interferon pathway. We identified 15 guinea pig IFNA1 gene candidates upon bioinformatic analysis and selected the three candidates with the highest sequence homology to Homo sapiens, Mus musculus and Marmota himalayana IFNA1. The anti-viral activity of guinea pig IFN-Alphal protein against influenza virus A/Puerto Rico/8/34- or endomyocarditis virus-infection was then determined for the three gene candidates. We identified cpIFNA1 as the candidate with the highest sequence homologies and best anti-viral effects. cpIFNA1 will enable us to perform a proof-of-concept experiment to verify that IFN-Alphal AS increases cpIFNA1 mRNA levels, resulting in inhibition of influenza virus proliferation in vivo.